Select news about:
December 2022
-
Dec. 28, 2022Pía Garat is a biotechnology engineer, CEO, and co-founder of Eolo Pharma, a company that will make history in 2023 with molecules developed entirely in Uruguay. A drug they have developed for the prevention and treatment of obesity and related complications will begin Phase I clinical trials in humans. This will mark a milestone at both the national and regional levels.
-
Dec. 6, 2022Florencia Skuras, a graduate in Biotechnology Engineering, traveled to England in late 2021 to pursue a master’s degree in bioinformatics. What began as a dream not only came true, but she also completed her master’s program by receiving the MSc Genomics Prize for her academic excellence.
-
Dec. 2, 2022Mauricio Pintado, a graduate of ORT’s Specialization Diploma in Human Resources, spoke about the business and social impact of the startup he co-leads, which is incubated at the CIE.
-
Dec. 1, 2022Fernando Slamovitz, a graduate in Biotechnology Engineering, is the creator of YEDA, an app designed to give people with diabetes greater independence in managing their treatment and the information they need to make better decisions. With this venture, he has just won the #elBiGPitch contest, organized by the da Vinci Foundation. In this interview, he explains how his interest in creating this app arose, how it works, and recalls his time at the Weizmann Institute in Israel, where he completed his specialization in the field.
-
Dec. 1, 2022Lucia Casarotti and Paulina Sfeir, students in the Bachelor’s program in International Studies at the School of Management and Social Sciences at Universidad ORT Uruguay, received an honorable mention in the team category of the 2022 Astur Award.